Perbedaan Griptha Putra Persada Tbk. dan Tempo Scan Pacific Tbk.: Griptha Putra Persada Tbk. diperdagangkan di Rp59 (kapitalisasi pasar 60 M, volume 24 jam 661,3 rb), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.520 (kapitalisasi pasar 11,18 T, volume 24 jam 613 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 186,3× kapitalisasi pasar Griptha Putra Persada Tbk., dan Griptha Putra Persada Tbk. lebih aktif diperdagangkan (661,3 rb vs 613 rb). Mana yang lebih baik tergantung tujuan investasimu.
| GRPH | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 60 M | 11,18 T |
Volume | 661,3 rb | 613 rb |
Lot | 6,61 rb | 6,13 rb |
Perputaran | 39,67 jt | 1,54 M |
Harga Rata-rata | 59,99 | 2.511,52 |
Nilai Transaksi | 39,67 jt | 1,54 M |
Harga Ekuilibrium Indikatif | 59 | 2.520 |
Volume Ekuilibrium Indikatif | 640 | 17 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.
Selengkapnya di halaman GRPH →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →